UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Placebo-controlled pilot trial testing dose titration and intravenous, intramuscular and subcutaneous routes for ketamine in depression

Acta psychiatrica Scandinavica, 2016-07, Vol.134 (1), p.48-56

2016

Volltextzugriff (PDF)

Model-based Drug Development

Clinical pharmacology and therapeutics, 2007-07, Vol.82 (1), p.21-32

2007

Volltextzugriff (PDF)

Pregabalin for painful HIV neuropathy: a randomized, double-blind, placebo-controlled trial

Neurology, 2010-02, Vol.74 (5), p.413-420

2010

Volltextzugriff (PDF)

Systematic review of cognitive development across childhood in Down syndrome: implications for treatment interventions

Journal of intellectual disability research, 2013-04, Vol.57 (4), p.306-318

2013

Volltextzugriff (PDF)

Ketamine and neuroticism: a double-hit hypothesis of internalizing disorders

Personality neuroscience, 2020, Vol.3, p.e2-e2, Article e2

2020

Volltextzugriff (PDF)

An improved human anxiety process biomarker: characterization of frequency band, personality and pharmacology

Translational psychiatry, 2015-12, Vol.5 (12), p.e699-e699

2015

Volltextzugriff (PDF)

Pegylated interferon-α2b: Pharmacokinetics, pharmacodynamics, safety, and preliminary efficacy data

Clinical pharmacology and therapeutics, 2000-11, Vol.68 (5), p.556-567

2000

Volltextzugriff (PDF)

Thorough QT Study with Recommended and Supratherapeutic Doses of Tolterodine

Clinical pharmacology and therapeutics, 2007-03, Vol.81 (3), p.377-385

2007

Volltextzugriff (PDF)

Switching to Long-Acting Injectable Risperidone is Beneficial with Regard to Clinical Outcomes, Regardless of Previous Conventional Medication in Patients with Schizophrenia

Pharmacopsychiatry, 2007-11, Vol.40 (6), p.257-263

2007

Volltextzugriff (PDF)

The clinical pharmacology of ribavirin

Seminars in liver disease, 1999, Vol.19 Suppl 1, p.17

Glue, P

1999

Volltextzugriff (PDF)

Response to "Feedback to Tolterodine QT"

Clinical pharmacology and therapeutics, 2008-02, Vol.83 (2), p.233-233

2008

Volltextzugriff (PDF)

Patients in the early phases of schizophrenia and schizoaffective disorders effectively treated with risperidone long-acting injectable

Journal of psychopharmacology (Oxford), 2005-09, Vol.19 (5_suppl), p.5-14

2005

Volltextzugriff (PDF)

P985 Pharmacokinetic interaction and dose adjustment for combined use of voriconazole and efavirenz

International journal of antimicrobial agents, 2007, Vol.29, p.S261-S262

2007

Volltextzugriff (PDF)

Safety of interferon and ribavirin therapy in haemodialysis patients with chronic hepatitis C: results of a pilot study

Nephrology, dialysis, transplantation, 2001-01, Vol.16 (1), p.193-195

2001

Volltextzugriff (PDF)

Cytochrome P450 enzymes and drug metabolism--basic concepts and methods of assessment

Cellular and molecular neurobiology, 1999-06, Vol.19 (3), p.309-323

1999

Volltextzugriff (PDF)

Population pharmacokinetic analysis of pegylated interferon alfa-2b and interferon alfa-2b in patients with chronic hepatitis C

Clinical pharmacology and therapeutics, 2001-06, Vol.69 (6), p.407-421

2001

Volltextzugriff (PDF)

The impact of total calories and fat content on steady-state serum ziprasidone concentrations in patients receiving oral ziprasidone

European psychiatry, 2007-03, Vol.22, p.S153-S153

2007

Volltextzugriff (PDF)

Optimal treatment of social phobia: systematic review and meta-analysis

Neuropsychiatric disease and treatment, 2012-01, Vol.8 (default), p.203-215

2012

Volltextzugriff (PDF)

Oral bioavailability of desloratadine is unaffected by food

Clinical pharmacokinetics, 2002, Vol.41 Suppl 1 (Supplement 1), p.7-12

2002

Volltextzugriff (PDF)

P.3.c.067 Effect of meal size and fat content on oral ziprasidone absorption

European neuropsychopharmacology, 2007, Vol.17, p.S463-S463

2007

Volltextzugriff (PDF)

Switching to long-acting injectable risperidone: Beneficial with regard to clinical outcomes, regardless of previous conventional medication in patients with schizophrenia

European psychiatry, 2007-03, Vol.22, p.S159-S159

2007

Volltextzugriff (PDF)

A Dose-Ranging Study of Pegylated Interferon Alfa-2b and Ribavirin in Chronic Hepatitis C

Hepatology (Baltimore, Md.), 2000-09, Vol.32 (3), p.647-653

2000

Volltextzugriff (PDF)

Effects of felbamate on the pharmacokinetics of a low-dose combination oral contraceptive

Clinical pharmacology and therapeutics, 1995-11, Vol.58 (5), p.523-531

1995

Volltextzugriff (PDF)

Ascending Single-Dose, Double-Blind, Placebo-Controlled Safety Study of Noribogaine in Opioid-Dependent Patients

Clinical pharmacology in drug development, 2016-11, Vol.5 (6), p.460-468

2016

Volltextzugriff (PDF)

Rapid cycling affective disorders in the mentally retarded

Biological psychiatry (1969), 1989-07, Vol.26 (3), p.250-256

Glue, Paul

1989

Volltextzugriff (PDF)

1 – 25 von 193

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(171)
Mit Volltextzugriff
(157)

Publikationsform

Sprache

Englisch
(190)
Dänisch
(3)

Erscheinungsjahr

n.n

Thema

Science & Technology
(111)
Life Sciences & Biomedicine
(107)
Humans
(101)
Biological And Medical Sciences
(74)
Male
(68)
Medical Sciences
(65)
Adult
(63)
Female
(48)
Pharmacology & Pharmacy
(42)
Psychiatry
(42)
Pharmacology. Drug Treatments
(40)
Middle Aged
(36)
Neurosciences & Neurology
(27)
Psychology. Psychoanalysis. Psychiatry
(25)
Neuropharmacology
(24)
Aged
(17)
Neurosciences
(17)
Double-Blind Method
(15)
Animals
(14)
Adolescent
(13)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Placebo-controlled pilot trial testing dose titration and intravenous, intramuscular and subcutaneous routes for ketamine in depression

Model-based Drug Development

Pregabalin for painful HIV neuropathy: a randomized, double-blind, placebo-controlled trial

Systematic review of cognitive development across childhood in Down syndrome: implications for treatment interventions

Ketamine and neuroticism: a double-hit hypothesis of internalizing disorders

An improved human anxiety process biomarker: characterization of frequency band, personality and pharmacology

Pegylated interferon-α2b: Pharmacokinetics, pharmacodynamics, safety, and preliminary efficacy data

Thorough QT Study with Recommended and Supratherapeutic Doses of Tolterodine

Switching to Long-Acting Injectable Risperidone is Beneficial with Regard to Clinical Outcomes, Regardless of Previous Conventional Medication in Patients with Schizophrenia

The clinical pharmacology of ribavirin

Response to "Feedback to Tolterodine QT"

Patients in the early phases of schizophrenia and schizoaffective disorders effectively treated with risperidone long-acting injectable

P985 Pharmacokinetic interaction and dose adjustment for combined use of voriconazole and efavirenz

Safety of interferon and ribavirin therapy in haemodialysis patients with chronic hepatitis C: results of a pilot study

Cytochrome P450 enzymes and drug metabolism--basic concepts and methods of assessment

Population pharmacokinetic analysis of pegylated interferon alfa-2b and interferon alfa-2b in patients with chronic hepatitis C

The impact of total calories and fat content on steady-state serum ziprasidone concentrations in patients receiving oral ziprasidone

Optimal treatment of social phobia: systematic review and meta-analysis

Oral bioavailability of desloratadine is unaffected by food

P.3.c.067 Effect of meal size and fat content on oral ziprasidone absorption

Switching to long-acting injectable risperidone: Beneficial with regard to clinical outcomes, regardless of previous conventional medication in patients with schizophrenia

A Dose-Ranging Study of Pegylated Interferon Alfa-2b and Ribavirin in Chronic Hepatitis C

Effects of felbamate on the pharmacokinetics of a low-dose combination oral contraceptive

Ascending Single-Dose, Double-Blind, Placebo-Controlled Safety Study of Noribogaine in Opioid-Dependent Patients

Rapid cycling affective disorders in the mentally retarded

Suchergebnisse filtern